Breaking News, Financial News

Financial Report: Catalent Pharma Solutions

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Catalent Pharma Solutions 2Q Revenues: $464 million (+11%) 2Q Loss: $30.2 million (earnings were $18.5 million 4Q06) YTD Revenues: $902 million (+11%) YTD Loss: $41.5 million (earnings were $19.6 million YTD06) Comments: Revenue growth was primarily due to demand for Oral Technologies pharmaceutical products and increased volumes and throughput in the Sterile Technologies segment, including increased output from the new sterile facility in Belgium. Oral Technologies revenue in th...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters